The first haemophilia B patient in Germany has been treated with the one-time gene therapy HEMGENIX at the Hemophilia Treatment Center at Hannover Medical School, CSL Behring Germany has announced.

CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...

Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...

Columnist Joe MacDonald describes his early adjustments to cope with the reality of his oldest son's hemophilia.

The Government of Kerala oversees the Kerala State Lotteries program. It was founded in 1967 and is the first of its kind in ...

The Ukrainian government has proposed an additional Hr.400.5 billion ($9.7 billion) in war-related spending through a draft ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. TaxStatus is the only firm to provide the comprehensive information advisors need to ...

If you have a long-term illness or disability and you’ve reached State Pension age, you may be entitled to a benefit called ...

Eligible Brits typically need to have a condition 'severe enough' to require care or supervision from another person ...

Procedure was performed on 54-yr-old patient from Jharkhand suffering from advanced osteoarthritis and severe knee ...

Syracuse, N.Y. — The 2025 Tri-Valley League baseball all-stars were recently released.